A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Å6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2011
At a glance
- Drugs A 6 (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 07 Jun 2011 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from recruiting to discontinued as reported in Gynecologic Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History